In this Section |
246980 SESSION ABSTRACT - NIATx200: The largest randomized controlled trial of quality improvement ever conducted in addiction treatmentTuesday, November 1, 2011: 12:30 PM
Quality improvement and emerging technologies have the potential to drive the type of organizational change required to transform the addiction treatment field. The purpose of this session is to present results from the NIATx 200 initiative, which is the largest randomized trial of organizational change ever conducted in addiction treatment and among the largest ever conducted in healthcare. Participating agencies (n=201) in five states (MA, MI, NY, OR, and WA) were randomized to one of four interventions—learning sessions, interest circle calls, coaching, and a combination of all three services. The study had the primary goal of identifying and understanding the active ingredients of a successful quality improvement methodology (named NIATx) by examining which of the four study interventions is the most effective in reducing waiting time from first contact to first treatment, improving continuation through the fourth treatment, and increasing program admissions. This session will frame the research study; address the intervention effects on primary outcomes; explore characteristics related to organizations' willingness to enroll in and influence study participation; and examine how organizational variables moderate improvement in the primary outcomes across the study interventions. The presentation order is Abstract #: 246758/Length: 25 Minutes; Abstract #: 246867/Length: 25 Minutes; Abstract #: 246915/Length: 20 Minutes and Abstract #: 246946/Length: 20 Minutes
Learning Areas:
Administration, management, leadershipConduct evaluation related to programs, research, and other areas of practice Learning Objectives: Keywords: Quality Improvement, Research
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I am an Assistant Scientist who served as the co-investigator for this grant and contributed to its design, implementation and analysis phases I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
See more of: NIATX: Quality Improvement Can Transform the Addiction Field
See more of: Alcohol, Tobacco, and Other Drugs |